On the other hand, insufficient evidence supports an altered analgesic response or dosing suggestions for such variants.[19] This concept illustrates the complexity of genetic polymorphisms plus the clinical implications associated with opioid therapy. A monitored location is recommended for high-hazard patients beginning opioid therapy or underg